Clark Kenneth A has filed 9 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 17796 shares of Summit Therapeutics Inc. ($SMMT) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Summit Therapeutics Inc. | $SMMT | Clark Kenneth A | Director | A | Stock Option (right to buy) | 17796 | $8.76 | 17,796.0000 | 744,442,538 | 9999.99% | 0.00% |
| Jan. 2, 2026 | Summit Therapeutics Inc. | $SMMT | Clark Kenneth A | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 744,442,538 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Summit Therapeutics Inc. | $SMMT | Clark Kenneth A | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Summit Therapeutics Inc. | $SMMT | Clark Kenneth A | Director | A | Stock Option (right to buy) | 16991 | $9.18 | 16,991.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2024 | Summit Therapeutics Inc. | $SMMT | Clark Kenneth A | Director | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Summit Therapeutics Inc. | $SMMT | Clark Kenneth A | Director | A | Stock Option (right to buy) | 70492 | $1.32 | 105,492.0000 | 0 | 201.41% | 0.00% |
| Jan. 2, 2024 | Summit Therapeutics Inc. | $SMMT | Clark Kenneth A | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Summit Therapeutics Inc. | $SMMT | Clark Kenneth A | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Summit Therapeutics Inc. | $SMMT | Clark Kenneth A | Director | A | Stock Option (right to buy) | 44400 | $1.67 | 79,400.0000 | 0 | 126.86% | 0.00% |